

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.43705112 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.91400324 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.91400324 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.43083891 |
| 5 | microglial cell activation (GO:0001774) | 4.40353447 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.09650098 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.09650098 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.06055038 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.06055038 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.06055038 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.06055038 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.06055038 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.06055038 |
| 14 | response to muramyl dipeptide (GO:0032495) | 4.03426773 |
| 15 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.01105928 |
| 16 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.71682391 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.71322695 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 3.69499673 |
| 19 | negative regulation of granulocyte differentiation (GO:0030853) | 3.67590265 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.62126028 |
| 21 | detection of other organism (GO:0098543) | 3.55973632 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52805504 |
| 23 | detection of bacterium (GO:0016045) | 3.43167732 |
| 24 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.40767458 |
| 25 | regulation of germinal center formation (GO:0002634) | 3.36909860 |
| 26 | mature B cell differentiation (GO:0002335) | 3.36152504 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.31532154 |
| 28 | NIK/NF-kappaB signaling (GO:0038061) | 3.31179000 |
| 29 | germinal center formation (GO:0002467) | 3.30341898 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.29533858 |
| 31 | cellular extravasation (GO:0045123) | 3.26566644 |
| 32 | negative thymic T cell selection (GO:0045060) | 3.24897269 |
| 33 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.22653698 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.18419650 |
| 35 | response to interleukin-15 (GO:0070672) | 3.17698522 |
| 36 | regulation of cellular extravasation (GO:0002691) | 3.16699107 |
| 37 | negative regulation of interleukin-6 production (GO:0032715) | 3.13453671 |
| 38 | negative T cell selection (GO:0043383) | 3.12633543 |
| 39 | macrophage activation (GO:0042116) | 3.12118974 |
| 40 | positive regulation of B cell differentiation (GO:0045579) | 3.12085112 |
| 41 | mature B cell differentiation involved in immune response (GO:0002313) | 3.10253260 |
| 42 | regulation of monocyte differentiation (GO:0045655) | 3.07192389 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.06611287 |
| 44 | myeloid dendritic cell activation (GO:0001773) | 3.06410734 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 3.05865225 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.04997252 |
| 47 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.04020993 |
| 48 | myeloid dendritic cell differentiation (GO:0043011) | 3.03515435 |
| 49 | negative regulation of innate immune response (GO:0045824) | 3.02987777 |
| 50 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00897994 |
| 51 | positive regulation of chemokine secretion (GO:0090197) | 3.00152713 |
| 52 | positive regulation of interferon-alpha production (GO:0032727) | 2.99749019 |
| 53 | negative regulation of protein autophosphorylation (GO:0031953) | 2.97124238 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 2.96735300 |
| 55 | defense response to protozoan (GO:0042832) | 2.96221904 |
| 56 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.94286078 |
| 57 | detection of external biotic stimulus (GO:0098581) | 2.92792188 |
| 58 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.92022566 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.91564156 |
| 60 | definitive hemopoiesis (GO:0060216) | 2.90938364 |
| 61 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.89186199 |
| 62 | regulation of B cell differentiation (GO:0045577) | 2.88042881 |
| 63 | regulation of interferon-alpha production (GO:0032647) | 2.87399907 |
| 64 | tolerance induction (GO:0002507) | 2.85966177 |
| 65 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.85454546 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85040638 |
| 67 | germ cell migration (GO:0008354) | 2.83740230 |
| 68 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82144208 |
| 69 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82144208 |
| 70 | T cell selection (GO:0045058) | 2.81426843 |
| 71 | regulation of chemokine secretion (GO:0090196) | 2.81358414 |
| 72 | T cell migration (GO:0072678) | 2.80246520 |
| 73 | response to type I interferon (GO:0034340) | 2.78620176 |
| 74 | regulation of antigen processing and presentation (GO:0002577) | 2.78116469 |
| 75 | positive T cell selection (GO:0043368) | 2.77717735 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77179979 |
| 77 | type I interferon signaling pathway (GO:0060337) | 2.75561890 |
| 78 | cellular response to type I interferon (GO:0071357) | 2.75561890 |
| 79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75415732 |
| 80 | neutrophil activation (GO:0042119) | 2.75178172 |
| 81 | negative regulation of interleukin-1 production (GO:0032692) | 2.74837140 |
| 82 | thymic T cell selection (GO:0045061) | 2.74750756 |
| 83 | detection of biotic stimulus (GO:0009595) | 2.74188510 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.74133205 |
| 85 | detection of molecule of bacterial origin (GO:0032490) | 2.74087190 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 2.73415399 |
| 87 | positive thymic T cell selection (GO:0045059) | 2.72835842 |
| 88 | response to laminar fluid shear stress (GO:0034616) | 2.71200551 |
| 89 | negative regulation of interleukin-8 production (GO:0032717) | 2.71081813 |
| 90 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70266187 |
| 91 | embryonic process involved in female pregnancy (GO:0060136) | 2.67646520 |
| 92 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.67312134 |
| 93 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.66813545 |
| 94 | neutrophil mediated immunity (GO:0002446) | 2.66664410 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.66061332 |
| 96 | dendritic cell differentiation (GO:0097028) | 2.64063532 |
| 97 | response to peptidoglycan (GO:0032494) | 2.63747715 |
| 98 | granulocyte activation (GO:0036230) | 2.63491354 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63254760 |
| 100 | positive regulation of type 2 immune response (GO:0002830) | 2.63196465 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62486660 |
| 102 | response to host immune response (GO:0052572) | 2.62486660 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 2.62335350 |
| 104 | response to host (GO:0075136) | 2.62154324 |
| 105 | response to host defenses (GO:0052200) | 2.62154324 |
| 106 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.62154324 |
| 107 | positive regulation of tolerance induction (GO:0002645) | 2.61215454 |
| 108 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.59833376 |
| 109 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59613237 |
| 110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.58472625 |
| 111 | negative regulation of interleukin-12 production (GO:0032695) | 2.55044177 |
| 112 | positive regulation of p38MAPK cascade (GO:1900745) | 2.54995970 |
| 113 | response to progesterone (GO:0032570) | 2.54829437 |
| 114 | B cell receptor signaling pathway (GO:0050853) | 2.54758494 |
| 115 | leukocyte aggregation (GO:0070486) | 2.54029341 |
| 116 | regulation of T cell tolerance induction (GO:0002664) | 2.53667197 |
| 117 | myeloid leukocyte activation (GO:0002274) | 2.53259188 |
| 118 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.53144892 |
| 119 | T cell differentiation involved in immune response (GO:0002292) | 2.52892366 |
| 120 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.52892366 |
| 121 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.52892366 |
| 122 | interferon-gamma production (GO:0032609) | 2.52797263 |
| 123 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.52417162 |
| 124 | I-kappaB phosphorylation (GO:0007252) | 2.48166796 |
| 125 | thrombin receptor signaling pathway (GO:0070493) | 2.47777301 |
| 126 | positive regulation of interleukin-12 production (GO:0032735) | 2.46700477 |
| 127 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.40573115 |
| 128 | negative regulation of bone resorption (GO:0045779) | 2.39954446 |
| 129 | cytokine secretion (GO:0050663) | 2.38991576 |
| 130 | regulation of mast cell degranulation (GO:0043304) | 2.38718178 |
| 131 | T-helper 1 type immune response (GO:0042088) | 2.38039114 |
| 132 | growth hormone receptor signaling pathway (GO:0060396) | 2.38000849 |
| 133 | T-helper cell differentiation (GO:0042093) | 2.37334377 |
| 134 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.37334377 |
| 135 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.36787869 |
| 136 | B cell homeostasis (GO:0001782) | 2.36136612 |
| 137 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.35690716 |
| 138 | response to protozoan (GO:0001562) | 2.34322146 |
| 139 | regulation of interleukin-12 production (GO:0032655) | 2.34111278 |
| 140 | dendritic cell migration (GO:0036336) | 2.33545761 |
| 141 | B cell mediated immunity (GO:0019724) | 2.33297871 |
| 142 | positive regulation of cholesterol efflux (GO:0010875) | 2.32533260 |
| 143 | radial glial cell differentiation (GO:0060019) | 2.32449229 |
| 144 | positive regulation of interferon-beta production (GO:0032728) | 2.32253485 |
| 145 | hepatocyte apoptotic process (GO:0097284) | 2.31855236 |
| 146 | dendritic cell chemotaxis (GO:0002407) | 2.31457620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.06334031 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.74446172 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.45815154 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.10917717 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.93171753 |
| 6 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.41819475 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.33688110 |
| 8 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.24281141 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22494597 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.17990270 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.09064183 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.05656931 |
| 13 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.96094208 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.81856624 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.66408595 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.64213065 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63492305 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.61737062 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.61037422 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56001947 |
| 21 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31541725 |
| 22 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.20844827 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.17758663 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.10281420 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99219671 |
| 26 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.97529895 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.95465125 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87710833 |
| 29 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86997821 |
| 30 | * MAF_26560356_Chip-Seq_TH1_Human | 1.81204581 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78802652 |
| 32 | * MYB_26560356_Chip-Seq_TH2_Human | 1.78580626 |
| 33 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76759138 |
| 34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.69002238 |
| 35 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.68825009 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63332671 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62773634 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60505436 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60206720 |
| 40 | * MYB_26560356_Chip-Seq_TH1_Human | 1.55836551 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51852676 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51594445 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47166846 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46942514 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45503743 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44809457 |
| 47 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43179660 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41755147 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41457471 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39716102 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39638668 |
| 52 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.37925701 |
| 53 | * MAF_26560356_Chip-Seq_TH2_Human | 1.37057904 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34446346 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32413943 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31472403 |
| 57 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30199292 |
| 58 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.26353626 |
| 59 | * MYC_22102868_ChIP-Seq_BL_Human | 1.25165484 |
| 60 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.23827154 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22627094 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21440754 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21021882 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.20368554 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19415543 |
| 66 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19352016 |
| 67 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.18225007 |
| 68 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17976108 |
| 69 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16309917 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16085776 |
| 71 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.15973153 |
| 72 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.15973153 |
| 73 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.15973153 |
| 74 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15871381 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15220005 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14988267 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12426019 |
| 78 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12267223 |
| 79 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10966330 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09644340 |
| 81 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09644340 |
| 82 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09641741 |
| 83 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.08052623 |
| 84 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.07565583 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05476413 |
| 86 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.05125761 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05083815 |
| 88 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04094872 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02420522 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02125665 |
| 91 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01027672 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00551349 |
| 93 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00104336 |
| 94 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99991347 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98722403 |
| 96 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98519142 |
| 97 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97393255 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96382871 |
| 99 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95435490 |
| 100 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93781705 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93719889 |
| 102 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93303659 |
| 103 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92400900 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90282602 |
| 105 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90183831 |
| 106 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89967114 |
| 107 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.88501376 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88044659 |
| 109 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87638590 |
| 110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87543024 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86595747 |
| 112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85533901 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85422213 |
| 114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84148734 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83077778 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82687328 |
| 117 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.82480743 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82412925 |
| 119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82035230 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81796287 |
| 121 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.81686863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.70798056 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.47137388 |
| 3 | MP0003303_peritoneal_inflammation | 2.86921373 |
| 4 | MP0003436_decreased_susceptibility_to | 2.85462154 |
| 5 | MP0002254_reproductive_system_inflammat | 2.64736273 |
| 6 | MP0005671_abnormal_response_to | 2.62537588 |
| 7 | MP0001800_abnormal_humoral_immune | 2.50490057 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.48612046 |
| 9 | MP0001790_abnormal_immune_system | 2.47602920 |
| 10 | MP0005387_immune_system_phenotype | 2.47602920 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.47409110 |
| 12 | MP0000685_abnormal_immune_system | 2.41170122 |
| 13 | MP0004510_myositis | 2.40769863 |
| 14 | * MP0002419_abnormal_innate_immunity | 2.39008632 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.34908263 |
| 16 | MP0003828_pulmonary_edema | 2.27962860 |
| 17 | MP0002723_abnormal_immune_serum | 2.27950320 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.21179562 |
| 19 | MP0009785_altered_susceptibility_to | 2.15264679 |
| 20 | MP0009278_abnormal_bone_marrow | 2.14814246 |
| 21 | MP0005025_abnormal_response_to | 2.12461218 |
| 22 | MP0002396_abnormal_hematopoietic_system | 2.08255605 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.05571213 |
| 24 | MP0006082_CNS_inflammation | 2.03608841 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.00204259 |
| 26 | * MP0001819_abnormal_immune_cell | 2.00078542 |
| 27 | * MP0002420_abnormal_adaptive_immunity | 1.99753513 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.99144294 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.94853449 |
| 30 | MP0002405_respiratory_system_inflammati | 1.85094967 |
| 31 | MP0001873_stomach_inflammation | 1.75002767 |
| 32 | * MP0004947_skin_inflammation | 1.74848654 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.72784520 |
| 34 | * MP0001851_eye_inflammation | 1.66471645 |
| 35 | MP0002006_tumorigenesis | 1.63522440 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.61824985 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.58596584 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.58573882 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.57832330 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.57832330 |
| 41 | MP0000716_abnormal_immune_system | 1.57719811 |
| 42 | MP0002009_preneoplasia | 1.55948901 |
| 43 | * MP0001845_abnormal_inflammatory_respons | 1.55697936 |
| 44 | MP0002398_abnormal_bone_marrow | 1.55456541 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.44937756 |
| 46 | * MP0001853_heart_inflammation | 1.44132465 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.44005041 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.40142557 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.37363049 |
| 50 | MP0010368_abnormal_lymphatic_system | 1.37290599 |
| 51 | MP0003075_altered_response_to | 1.35655086 |
| 52 | MP0000343_altered_response_to | 1.33543193 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.33285853 |
| 54 | MP0005310_abnormal_salivary_gland | 1.31522935 |
| 55 | MP0003448_altered_tumor_morphology | 1.30677780 |
| 56 | MP0009764_decreased_sensitivity_to | 1.28505306 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.28202417 |
| 58 | MP0002429_abnormal_blood_cell | 1.26979276 |
| 59 | MP0005390_skeleton_phenotype | 1.26755857 |
| 60 | MP0001879_abnormal_lymphatic_vessel | 1.25878828 |
| 61 | MP0008469_abnormal_protein_level | 1.24633401 |
| 62 | * MP0002722_abnormal_immune_system | 1.24037871 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.23207321 |
| 64 | MP0001542_abnormal_bone_strength | 1.20890132 |
| 65 | MP0005023_abnormal_wound_healing | 1.20764026 |
| 66 | MP0002928_abnormal_bile_duct | 1.20605236 |
| 67 | MP0008004_abnormal_stomach_pH | 1.19766904 |
| 68 | MP0003045_fibrosis | 1.18710108 |
| 69 | MP0003866_abnormal_defecation | 1.14824705 |
| 70 | MP0000858_altered_metastatic_potential | 1.12767205 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.12420100 |
| 72 | MP0000249_abnormal_blood_vessel | 1.06559144 |
| 73 | * MP0002933_joint_inflammation | 1.06018848 |
| 74 | MP0005058_abnormal_lysosome_morphology | 1.05760133 |
| 75 | MP0004883_abnormal_blood_vessel | 1.05347921 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.05061259 |
| 77 | MP0003279_aneurysm | 1.02804590 |
| 78 | MP0002060_abnormal_skin_morphology | 1.00252381 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.99534968 |
| 80 | MP0010352_gastrointestinal_tract_polyps | 0.96521049 |
| 81 | * MP0000703_abnormal_thymus_morphology | 0.94357037 |
| 82 | MP0005164_abnormal_response_to | 0.93214269 |
| 83 | MP0005257_abnormal_intraocular_pressure | 0.91322154 |
| 84 | MP0005166_decreased_susceptibility_to | 0.90432775 |
| 85 | MP0000604_amyloidosis | 0.88565285 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.88434183 |
| 87 | MP0001216_abnormal_epidermal_layer | 0.88035612 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.87960062 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.87318489 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.85999795 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.85953668 |
| 92 | MP0003690_abnormal_glial_cell | 0.85681354 |
| 93 | MP0003795_abnormal_bone_structure | 0.85500352 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.83589551 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.81081688 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.80494804 |
| 97 | MP0009840_abnormal_foam_cell | 0.79804171 |
| 98 | MP0001191_abnormal_skin_condition | 0.79626017 |
| 99 | MP0008260_abnormal_autophagy | 0.77817444 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.77394694 |
| 101 | MP0002132_abnormal_respiratory_system | 0.76456777 |
| 102 | MP0001958_emphysema | 0.74104629 |
| 103 | MP0000383_abnormal_hair_follicle | 0.73774179 |
| 104 | MP0003091_abnormal_cell_migration | 0.73257190 |
| 105 | MP0006054_spinal_hemorrhage | 0.73231618 |
| 106 | MP0009763_increased_sensitivity_to | 0.72557764 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.72050567 |
| 108 | MP0002133_abnormal_respiratory_system | 0.70915585 |
| 109 | MP0005388_respiratory_system_phenotype | 0.70915585 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.70686931 |
| 111 | MP0004381_abnormal_hair_follicle | 0.68757312 |
| 112 | MP0001663_abnormal_digestive_system | 0.68385438 |
| 113 | MP0001243_abnormal_dermal_layer | 0.65172794 |
| 114 | MP0004130_abnormal_muscle_cell | 0.58801996 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.58723376 |
| 116 | MP0008995_early_reproductive_senescence | 0.57854375 |
| 117 | MP0005535_abnormal_body_temperature | 0.57732097 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.56218809 |
| 119 | MP0009115_abnormal_fat_cell | 0.55871352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.95227199 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 4.89187567 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.49093190 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.34026384 |
| 5 | Hematochezia (HP:0002573) | 3.98941380 |
| 6 | Myositis (HP:0100614) | 3.97144524 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85621143 |
| 8 | Glomerulonephritis (HP:0000099) | 3.68336805 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.50520572 |
| 10 | Orchitis (HP:0100796) | 3.41776977 |
| 11 | Chronic otitis media (HP:0000389) | 3.40146843 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28133336 |
| 13 | Recurrent skin infections (HP:0001581) | 3.23444869 |
| 14 | Spontaneous hematomas (HP:0007420) | 3.22352288 |
| 15 | Interstitial pulmonary disease (HP:0006530) | 3.15151201 |
| 16 | Arterial tortuosity (HP:0005116) | 3.14694927 |
| 17 | Colitis (HP:0002583) | 3.11048513 |
| 18 | Aortic aneurysm (HP:0004942) | 3.05140873 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.04241209 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.99383611 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 2.99383611 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 2.91907329 |
| 23 | Cellulitis (HP:0100658) | 2.89866273 |
| 24 | Chronic diarrhea (HP:0002028) | 2.87923797 |
| 25 | Vascular tortuosity (HP:0004948) | 2.87805591 |
| 26 | Prostate neoplasm (HP:0100787) | 2.87160345 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.87079644 |
| 28 | Optic neuritis (HP:0100653) | 2.87079644 |
| 29 | Cerebral aneurysm (HP:0004944) | 2.83452548 |
| 30 | Inflammation of the large intestine (HP:0002037) | 2.82072035 |
| 31 | Periodontitis (HP:0000704) | 2.80176856 |
| 32 | T lymphocytopenia (HP:0005403) | 2.79455333 |
| 33 | Encephalitis (HP:0002383) | 2.76372666 |
| 34 | Complement deficiency (HP:0004431) | 2.75460748 |
| 35 | Myocardial infarction (HP:0001658) | 2.73078316 |
| 36 | Abnormality of T cell number (HP:0011839) | 2.71212164 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.70316593 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.69904523 |
| 39 | Recurrent viral infections (HP:0004429) | 2.68727537 |
| 40 | Pustule (HP:0200039) | 2.68296571 |
| 41 | Episodic fever (HP:0001954) | 2.66323219 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.65607486 |
| 43 | Arterial thrombosis (HP:0004420) | 2.63264856 |
| 44 | Gingival bleeding (HP:0000225) | 2.61711693 |
| 45 | Vasculitis (HP:0002633) | 2.60760713 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.59796558 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.57477041 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 2.57184031 |
| 49 | IgM deficiency (HP:0002850) | 2.56959884 |
| 50 | Abnormality of T cells (HP:0002843) | 2.51228091 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47153520 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47153520 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47153520 |
| 54 | Leukocytosis (HP:0001974) | 2.46975478 |
| 55 | Thick nail (HP:0001805) | 2.46975118 |
| 56 | Abnormal platelet function (HP:0011869) | 2.45795676 |
| 57 | Impaired platelet aggregation (HP:0003540) | 2.45795676 |
| 58 | Eosinophilia (HP:0001880) | 2.43964856 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.43948176 |
| 60 | Increased IgE level (HP:0003212) | 2.43709597 |
| 61 | Epistaxis (HP:0000421) | 2.43500667 |
| 62 | Chest pain (HP:0100749) | 2.43485643 |
| 63 | Gingivitis (HP:0000230) | 2.43027619 |
| 64 | Papilledema (HP:0001085) | 2.42895850 |
| 65 | Axonal loss (HP:0003447) | 2.39593621 |
| 66 | Urticaria (HP:0001025) | 2.39085882 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.38152193 |
| 68 | Thrombocytosis (HP:0001894) | 2.36301287 |
| 69 | Gangrene (HP:0100758) | 2.35560614 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.35440709 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.33446770 |
| 72 | Meningitis (HP:0001287) | 2.33297581 |
| 73 | Pulmonary embolism (HP:0002204) | 2.33010654 |
| 74 | Nephritis (HP:0000123) | 2.32950889 |
| 75 | Alveolar cell carcinoma (HP:0006519) | 2.30205676 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.29126017 |
| 77 | Cheilitis (HP:0100825) | 2.27607532 |
| 78 | Abnormality of complement system (HP:0005339) | 2.26724458 |
| 79 | Petechiae (HP:0000967) | 2.26723979 |
| 80 | Vacuolated lymphocytes (HP:0001922) | 2.26461223 |
| 81 | Hemoptysis (HP:0002105) | 2.24671610 |
| 82 | Aortic dissection (HP:0002647) | 2.24420250 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23954039 |
| 84 | Osteolytic defects of the hand bones (HP:0009699) | 2.23954039 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.23788760 |
| 86 | Spondylolisthesis (HP:0003302) | 2.23241608 |
| 87 | Glomerulopathy (HP:0100820) | 2.23025252 |
| 88 | Joint swelling (HP:0001386) | 2.22986995 |
| 89 | Osteomyelitis (HP:0002754) | 2.21137465 |
| 90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21103952 |
| 91 | Acute myeloid leukemia (HP:0004808) | 2.20302620 |
| 92 | Premature loss of primary teeth (HP:0006323) | 2.19814378 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 2.19571605 |
| 94 | IgG deficiency (HP:0004315) | 2.19176127 |
| 95 | Nasal polyposis (HP:0100582) | 2.18671589 |
| 96 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.17890617 |
| 97 | Malnutrition (HP:0004395) | 2.15525434 |
| 98 | Abnormality of eosinophils (HP:0001879) | 2.15365365 |
| 99 | Anorexia (HP:0002039) | 2.14962275 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 2.14731555 |
| 101 | Increased IgM level (HP:0003496) | 2.14097942 |
| 102 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.13036644 |
| 103 | Recurrent bronchitis (HP:0002837) | 2.11622197 |
| 104 | Stomatitis (HP:0010280) | 2.09884688 |
| 105 | Obstructive lung disease (HP:0006536) | 2.08443186 |
| 106 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08443186 |
| 107 | Stomach cancer (HP:0012126) | 2.06215713 |
| 108 | Anhidrosis (HP:0000970) | 2.06161698 |
| 109 | Vertigo (HP:0002321) | 2.05106558 |
| 110 | Panhypogammaglobulinemia (HP:0003139) | 2.03990840 |
| 111 | Granulocytopenia (HP:0001913) | 2.02751334 |
| 112 | Keratoconjunctivitis sicca (HP:0001097) | 2.01566726 |
| 113 | Amyloidosis (HP:0011034) | 2.00651365 |
| 114 | Keratoconjunctivitis (HP:0001096) | 2.00412924 |
| 115 | Abnormality of the nasal septum (HP:0000419) | 1.97852224 |
| 116 | Increased serum ferritin (HP:0003281) | 1.97614202 |
| 117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97409428 |
| 118 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97409428 |
| 119 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97409428 |
| 120 | Asymmetric septal hypertrophy (HP:0001670) | 1.97200964 |
| 121 | Growth hormone excess (HP:0000845) | 1.97088893 |
| 122 | Acne (HP:0001061) | 1.96796717 |
| 123 | Papilloma (HP:0012740) | 1.96538011 |
| 124 | Verrucae (HP:0200043) | 1.96538011 |
| 125 | Skin ulcer (HP:0200042) | 1.96420678 |
| 126 | Emphysema (HP:0002097) | 1.95754631 |
| 127 | Gastrointestinal stroma tumor (HP:0100723) | 1.94518274 |
| 128 | Vertebral compression fractures (HP:0002953) | 1.94011740 |
| 129 | Abnormality of the prostate (HP:0008775) | 1.92854983 |
| 130 | Milia (HP:0001056) | 1.91059009 |
| 131 | Abnormality of the fingertips (HP:0001211) | 1.90953822 |
| 132 | Recurrent pneumonia (HP:0006532) | 1.88440652 |
| 133 | Striae distensae (HP:0001065) | 1.88085353 |
| 134 | Persistence of primary teeth (HP:0006335) | 1.86945331 |
| 135 | Thyroiditis (HP:0100646) | 1.86862013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.88106143 |
| 2 | MAPK15 | 4.67602722 |
| 3 | MAP3K14 | 3.16244816 |
| 4 | MAP4K1 | 2.49307613 |
| 5 | TYK2 | 2.46500603 |
| 6 | GRK6 | 2.41605363 |
| 7 | TBK1 | 2.30855420 |
| 8 | IKBKB | 2.29302443 |
| 9 | GRK7 | 2.12839727 |
| 10 | PRPF4B | 2.10993893 |
| 11 | IRAK4 | 2.04309304 |
| 12 | ERN1 | 1.98692192 |
| 13 | IKBKE | 1.97227691 |
| 14 | EPHB1 | 1.96473957 |
| 15 | MAP2K2 | 1.95225638 |
| 16 | KIT | 1.86987573 |
| 17 | TXK | 1.83025842 |
| 18 | STK10 | 1.82353211 |
| 19 | IRAK3 | 1.75901995 |
| 20 | CSF1R | 1.73673661 |
| 21 | ITK | 1.66943899 |
| 22 | JAK3 | 1.61919883 |
| 23 | JAK1 | 1.59630597 |
| 24 | EPHA3 | 1.58761437 |
| 25 | CHUK | 1.58350248 |
| 26 | TIE1 | 1.56604570 |
| 27 | ZAP70 | 1.49632762 |
| 28 | BLK | 1.46095971 |
| 29 | TNK2 | 1.44747761 |
| 30 | RIPK4 | 1.42670134 |
| 31 | FGFR4 | 1.38885767 |
| 32 | TEC | 1.35194029 |
| 33 | MAP3K3 | 1.32846191 |
| 34 | MAP2K3 | 1.28122128 |
| 35 | BTK | 1.27893335 |
| 36 | NLK | 1.24456944 |
| 37 | RIPK1 | 1.24148215 |
| 38 | SIK3 | 1.23888043 |
| 39 | BMPR2 | 1.21550663 |
| 40 | VRK1 | 1.21158195 |
| 41 | PIM2 | 1.20508561 |
| 42 | CSK | 1.18623899 |
| 43 | MAPK7 | 1.18001152 |
| 44 | TSSK6 | 1.16908898 |
| 45 | RPS6KA4 | 1.14590261 |
| 46 | MAP3K13 | 1.13763994 |
| 47 | MAP3K11 | 1.12065372 |
| 48 | KDR | 1.10318708 |
| 49 | FGFR3 | 1.07929513 |
| 50 | MAP3K1 | 1.00715328 |
| 51 | TAOK1 | 1.00489314 |
| 52 | HCK | 0.98840907 |
| 53 | MARK2 | 0.97386873 |
| 54 | TGFBR1 | 0.96085524 |
| 55 | MAPKAPK5 | 0.94949504 |
| 56 | CDC42BPA | 0.94927368 |
| 57 | MATK | 0.94801902 |
| 58 | JAK2 | 0.92670490 |
| 59 | LCK | 0.91367628 |
| 60 | CAMK1D | 0.91058899 |
| 61 | TESK2 | 0.90354506 |
| 62 | TRIB3 | 0.88333574 |
| 63 | SIK1 | 0.87973194 |
| 64 | TAOK3 | 0.87520058 |
| 65 | NEK9 | 0.85772739 |
| 66 | PRKD2 | 0.85706569 |
| 67 | FLT3 | 0.84858164 |
| 68 | SYK | 0.84587160 |
| 69 | PIM1 | 0.84194763 |
| 70 | MAP3K7 | 0.83154469 |
| 71 | IRAK1 | 0.81579709 |
| 72 | LYN | 0.77039209 |
| 73 | EIF2AK2 | 0.75668612 |
| 74 | IRAK2 | 0.75426549 |
| 75 | TAOK2 | 0.75032008 |
| 76 | CDK12 | 0.74260288 |
| 77 | MARK3 | 0.74177021 |
| 78 | CDK3 | 0.72890949 |
| 79 | PTK6 | 0.71772581 |
| 80 | PDK1 | 0.68486328 |
| 81 | HIPK2 | 0.68350778 |
| 82 | GSK3A | 0.68024808 |
| 83 | MAP3K10 | 0.67771762 |
| 84 | CDK6 | 0.67606366 |
| 85 | PIK3CG | 0.66156032 |
| 86 | CDK9 | 0.62885992 |
| 87 | MOS | 0.59782117 |
| 88 | FGR | 0.59541393 |
| 89 | RPS6KA6 | 0.59233751 |
| 90 | SIK2 | 0.58175612 |
| 91 | PAK2 | 0.58169016 |
| 92 | * MAPKAPK2 | 0.57599869 |
| 93 | MAPK12 | 0.56892459 |
| 94 | CLK1 | 0.56631626 |
| 95 | PDPK1 | 0.54646204 |
| 96 | RPS6KA5 | 0.53878399 |
| 97 | ADRBK2 | 0.50435041 |
| 98 | BMPR1B | 0.49330896 |
| 99 | CAMK1G | 0.48716990 |
| 100 | RPS6KA1 | 0.47713726 |
| 101 | RPS6KC1 | 0.46826147 |
| 102 | RPS6KL1 | 0.46826147 |
| 103 | MST4 | 0.45861027 |
| 104 | FES | 0.45356696 |
| 105 | LRRK2 | 0.44824853 |
| 106 | TRPM7 | 0.44471104 |
| 107 | NUAK1 | 0.44407637 |
| 108 | PRKAA2 | 0.44351465 |
| 109 | * MAPK3 | 0.44015483 |
| 110 | ABL1 | 0.43141517 |
| 111 | PRKD1 | 0.43117964 |
| 112 | IGF1R | 0.42488115 |
| 113 | PDGFRB | 0.41379116 |
| 114 | RPS6KA2 | 0.39874440 |
| 115 | PRKCQ | 0.39684455 |
| 116 | PAK4 | 0.39082541 |
| 117 | MAP3K6 | 0.38044254 |
| 118 | EEF2K | 0.36982131 |
| 119 | DMPK | 0.36681558 |
| 120 | CAMK4 | 0.35945667 |
| 121 | FYN | 0.35873926 |
| 122 | PRKG2 | 0.35035530 |
| 123 | DYRK1B | 0.33425033 |
| 124 | PDK2 | 0.33090210 |
| 125 | SGK3 | 0.32923598 |
| 126 | CDK8 | 0.32873481 |
| 127 | * MAPK4 | 0.32709773 |
| 128 | PTK2B | 0.32581349 |
| 129 | SGK2 | 0.30839825 |
| 130 | RET | 0.29272699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16787186 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.04538538 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.71618857 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.63181411 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.48036522 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34322618 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.25632484 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.10827407 |
| 9 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.05719982 |
| 10 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.97410976 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94325774 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.86075310 |
| 13 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.83507391 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82007389 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.76005899 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.73603976 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68293446 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63440880 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.63311187 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.62837477 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61454345 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.59349862 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53399612 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47766689 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.47567806 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46911436 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.46633244 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46332907 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41598927 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36866146 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35816200 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.34202516 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.34199299 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30010556 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.26238505 |
| 36 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.25921152 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23342470 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22241672 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.21922108 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21797277 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20754453 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.16759932 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14652186 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.14440476 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.11375525 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06913086 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.06391380 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.05758773 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.04003484 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03906756 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03703732 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01809882 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97624398 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94439302 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89995359 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89085490 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 0.87327803 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.85409568 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84408236 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81329366 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.79280736 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75013589 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73626646 |
| 64 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.72588406 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.69954588 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.67652945 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65288283 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.65004116 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64839863 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63815272 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63404657 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61941942 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61464859 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60413791 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60141652 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59494700 |
| 77 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59119421 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58476275 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58258954 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57136861 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.57133933 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56180949 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56018576 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.55098811 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54204945 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.53895850 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53744848 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53481508 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53252062 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51940861 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49793772 |
| 92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48255999 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.46140098 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46061490 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45598214 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44659338 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44540395 |
| 98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44013478 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43187706 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41052463 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39374846 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39312996 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.39274935 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38930968 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38774617 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38425448 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38283605 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38096207 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.37861372 |
| 110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37053134 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36512051 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34945511 |
| 113 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33933435 |
| 114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33534360 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.33430848 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33329739 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32817330 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30564709 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29747822 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27243330 |

